Feature Type | Standardized |
Nominal ANOVA |
||||
---|---|---|---|---|---|---|
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |